EHF and prostate carcinoma: Subsequent studies demonstrated that EHF re-expression in prostate cancer cells inhibited stem like properties and promoted epithelial differentiation by repressing EMT drivers, such as TWIST1, ZEB2, NANOG and POU5F1 [81].